Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 20/20 | 0.55 |
| ▸ | INSR | P06213 | 17/20 | 0.55 |
| ▸ | NPM1 | P06748 | 8/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | ABL1 | P00519 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.52 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.52 |
| ▸ | LCK | P06239 | 1/20 | 0.52 |
| ▸ | RET | P07949 | 1/20 | 0.52 |
| ▸ | IGF1R | P08069 | 1/20 | 0.52 |
| ▸ | MET | P08581 | 1/20 | 0.52 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.52 |
| ▸ | CDK2 | P24941 | 1/20 | 0.52 |
| ▸ | AKT1 | P31749 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 1/20 | 0.52 |
| ▸ | GSK3B | P49841 | 1/20 | 0.52 |
| ▸ | PLK1 | P53350 | 1/20 | 0.52 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.52 |
| ▸ | BTK | Q06187 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22985906 | 0.92 | ALK (0.46) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL18457930 | 0.86 | ALK (0.74) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL21539062 | 0.86 | ALK (0.54) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL21099672 | 0.82 | ALK (0.58) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL12245787 | 0.82 | ALK (0.75) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL17613285 | 0.81 | ALK (0.55) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL14479213 | 0.80 | ALK (0.56) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL23010799 | 0.78 | EGFR (0.49) | ALKINSRNPM1ABL1EGFR | |
| SCHEMBL21099420 | 0.77 | ALK (0.52) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL3960696 | 0.77 | ALK (0.68) | ALKINSRNPM1KCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3560959-B1 | ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF | NOVARTIS AG (CH) | 2023-11-22 | — | — | EP | disclosed |
| EP-3878465-A1 | COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3 | Novartis AG (CH) | 2021-09-15 | — | — | EP | disclosed |
| EP-3317301-B1 | COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3 | NOVARTIS AG (CH) | 2021-04-07 | — | — | EP | disclosed |
| EP-3778604-A1 | LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | Dana Farber Cancer Institute, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| EP-3778605-A2 | LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | Dana Farber Cancer Institute, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| EP-3660050-A1 | ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF | Novartis AG (CH) | 2020-06-03 | — | — | EP | disclosed |
| EP-3514179-A1 | ANTIBODY MOLECULES TO PD-1 AND USES THEREOF | Dana-Farber Cancer Institute, Inc. (US) | 2019-07-24 | — | — | EP | disclosed |